Keytruda Qlex is a subcutaneous formulation of pembrolizumab that offers a faster, more convenient alternative to IV administration with comparable efficacy.
Nina DiPierro, PharmD, BCOP
Advertisement
Articles by Nina DiPierro, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
3
Cancer Among 9/11 Survivors Is Accelerating 25 Years Later
4
Pharmacists Weigh Health, Not Just Weight, in Obesity Care
5